Considering the growing number of patients of lifestyle disease in India, domestic pharma player, Surya Pharmaceutical Ltd has entered into marketing tie up with USA-based Crocs Footwear, manufacturer of healthcare footwear specially designed for diabetic patients. Under the tie up Chandigarh-based Surya Pharmaceutical Ltd will market the product across India and also has plans to market their products in other SAARC countries.
In an interaction with Business Standard, Surya Pharmaceutical Ltd, President Corporate Finance, Hari Om Bhatia said, " There are 5 crore diabetic patients in India, which is also considered the diabetic capital of the world. Every year 150,000 amputations takes place just because of this disease. Also, diabetic population is growing by 10-15 per cent every year. Considering the data India is very big market for therapeutic footwears.”
